| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | 70 | $1.28B | +$35M | -$86.7M | -$51.7M | UL, BK, CME, AAPL, WELL | 13F-HR | 10/29/2024, 07:02 PM |
| Q2 2024 | 69 | $1.23B | +$21.8M | -$19.8M | +$2.02M | UL, CME, AAPL, SCHW, BK | 13F-HR | 7/30/2024, 03:59 PM |
| Q1 2024 | 67 | $1.26B | +$30.3M | -$20.7M | +$9.6M | CME, PEP, SCHW, DE, BK | 13F-HR | 4/30/2024, 01:14 PM |
| Q4 2023 | 62 | $1.19B | +$22.8M | -$27.6M | -$4.83M | CME, PEP, DE, SCHW, AAPL | 13F-HR | 2/12/2024, 10:54 AM |
| Q3 2023 | 58 | $1.1B | +$40.4M | -$152M | -$112M | CME, DE, PEP, UL, WELL | 13F-HR | 11/7/2023, 12:46 PM |
| Q2 2023 | 64 | $1.28B | +$143M | -$132M | +$10.4M | DE, PEP, AAPL, CME, UL | 13F-HR | 8/10/2023, 11:57 AM |
| Q1 2023 | 63 | $1.25B | +$54.3M | -$33.7M | +$20.6M | DE, PEP, CME, UL, WELL | 13F-HR | 5/4/2023, 07:38 AM |
| Q4 2022 | 60 | $1.23B | +$52.5M | -$42.4M | +$10.1M | DE, PEP, MRK, PG, UL | 13F-HR | 2/6/2023, 04:22 PM |
| Q3 2022 | 61 | $1.12B | +$76.2M | -$31.3M | +$44.9M | PEP, DE, CME, DEO, NTR | 13F-HR | 11/9/2022, 10:49 AM |
| Q2 2022 | 64 | $1.18B | +$87.4M | -$45.9M | +$41.5M | PEP, PG, WELL, CME, DE | 13F-HR | 8/10/2022, 03:50 PM |
| Q1 2022 | 65 | $1.29B | +$61.1M | -$23.9M | +$37.2M | DE, WELL, NTR, PG, PEP | 13F-HR | 5/10/2022, 01:19 PM |
| Q4 2021 | 67 | $1.27B | +$63.9M | -$29.6M | +$34.2M | PG, DE, DEO, PEP, WELL | 13F-HR | 2/8/2022, 12:38 PM |
| Q3 2021 | 65 | $1.15B | +$37.3M | -$33.8M | +$3.52M | DE, WELL, PG, DEO, PEP | 13F-HR | 11/15/2021, 10:44 AM |
| Q2 2021 | 66 | $1.17B | +$30.4M | -$20.1M | +$10.3M | DE, WELL, DEO, PG, PEP | 13F-HR | 8/11/2021, 02:19 PM |
| Q1 2021 | 62 | $1.1B | +$64.5M | -$19.3M | +$45.2M | DE, PG, WELL, CME, PEP | 13F-HR | 5/12/2021, 09:15 AM |
| Q4 2020 | 60 | $995M | +$19.9M | -$43.6M | -$23.7M | PG, DE, PEP, CME, DEO | 13F-HR | 2/11/2021, 11:59 AM |
| Q3 2020 | 59 | $919M | +$42.1M | -$30M | +$12.1M | PG, PEP, DE, MDLZ, CME | 13F-HR | 11/3/2020, 06:02 PM |
| Q2 2020 | 59 | $867M | +$27.5M | -$27.9M | -$387K | PG, PEP, MDLZ, CME, DEO | 13F-HR | 8/11/2020, 02:10 PM |
| Q1 2020 | 58 | $801M | +$107M | -$66.8M | +$39.9M | PG, PEP, CME, MDLZ, DEO | 13F-HR | 5/8/2020, 03:54 PM |
| Q4 2019 | 63 | $932M | +$33.9M | -$34.4M | -$586K | PG, WELL, MDLZ, PEP, DEO | 13F-HR | 2/11/2020, 03:55 PM |
| Q3 2019 | 62 | $913M | +$18.3M | -$44.4M | -$26.1M | PG, WELL, MDLZ, PEP, KO | 13F-HR | 10/30/2019, 03:59 PM |
| Q2 2019 | 65 | $922M | +$45.6M | -$15.4M | +$30.2M | PG, WELL, MDLZ, PEP, DEO | 13F-HR | 8/9/2019, 05:13 PM |
| Q1 2019 | 60 | $864M | +$45.3M | -$49.9M | -$4.66M | PG, WELL, MDLZ, PEP, DEO | 13F-HR | 5/13/2019, 10:48 AM |
| Q4 2018 | 60 | $813M | +$27.1M | -$25.8M | +$1.26M | PG, WELL, SNY, MDLZ, PFE | 13F-HR | 2/8/2019, 04:28 PM |
| Q3 2018 | 64 | $843M | +$23.4M | -$26.9M | -$3.48M | PG, WELL, MDLZ, SNY, PFE | 13F-HR | 11/6/2018, 09:50 AM |
| Q2 2018 | 61 | $808M | +$16.3M | -$12.5M | +$3.83M | PG, WELL, MDLZ, DEO, SNY | 13F-HR | 8/9/2018, 05:10 PM |
| Q1 2018 | 58 | $800M | +$81.4M | -$85.6M | -$4.18M | PG, MDLZ, SJM, DE, SNY | 13F-HR | 5/14/2018, 11:12 AM |
| Q4 2017 | 60 | $834M | +$45.2M | -$21.1M | +$24.1M | DE, MDLZ, DEO, SJM, JNJ | 13F-HR | 2/13/2018, 12:20 PM |
| Q3 2017 | 58 | $772M | +$112M | -$65.1M | +$47.2M | DE, SNY, MDLZ, DEO, KO | 13F-HR | 11/13/2017, 11:54 AM |
| Q2 2017 | 56 | $703M | +$28.1M | -$10.3M | +$17.7M | DE, SNY, KO, JNJ, DEO | 13F-HR | 8/10/2017, 10:22 AM |
| Q1 2017 | 58 | $667M | +$69.7M | -$69.1M | +$542K | DE, SNY, JNJ, KO, DEO | 13F-HR | 5/9/2017, 11:08 AM |
| Q4 2016 | 56 | $647M | +$49.1M | -$31.9M | +$17.1M | DE, TD, KO, JNJ, SNY | 13F-HR | 2/14/2017, 04:07 PM |
| Q3 2016 | 57 | $612M | +$34.5M | -$40M | -$5.42M | DE, JNJ, KO, TD, SNY | 13F-HR | 11/16/2016, 04:36 PM |
| Q2 2016 | 56 | $625M | +$32.6M | -$7.79M | +$24.8M | JNJ, KO, DE, SNY, TD | Restatement | 11/17/2016, 05:46 PM |
| Q1 2016 | 53 | $570M | +$44.7M | -$24.5M | +$20.2M | KO, JNJ, DE, TD, SNY | Restatement | 11/17/2016, 05:45 PM |
| Q4 2015 | 53 | $532M | +$36.3M | -$30.1M | +$6.15M | KO, JNJ, DE, SNY, L | Restatement | 11/17/2016, 05:44 PM |
| Q3 2015 | 55 | $515M | +$88.7M | -$60.4M | +$28.3M | KO, SNY, DE, JNJ, L | Restatement | 11/17/2016, 05:43 PM |
| Q2 2015 | 52 | $537M | +$37.9M | -$25.1M | +$12.8M | DE, KO, SNY, POT, BBL | Restatement | 11/17/2016, 05:41 PM |
| Q1 2015 | 54 | $542M | +$32.4M | -$14.1M | +$18.3M | DE, SNY, KO, POT, TTE | Restatement | 11/17/2016, 05:38 PM |
| Q4 2014 | 54 | $529M | +$64.9M | -$18.4M | +$46.5M | POT, DE, INTC, KO, TTE | Restatement | 11/17/2016, 05:37 PM |
| Q3 2014 | 53 | $483M | +$32M | -$21.8M | +$10.3M | POT, INTC, KO, TTE, RDSB | Restatement | 11/17/2016, 05:04 PM |
| Q2 2014 | 52 | $480M | +$67.6M | -$16.6M | +$51M | INTC, POT, RDSB, TTE, KO | 13F-HR | 8/13/2014, 10:11 AM |
| Q1 2014 | 48 | $407M | +$39.7M | -$59.1M | -$19.4M | INTC, POT, RDSB, TTE, KO | 13F-HR | 5/9/2014, 11:09 AM |
| Q4 2013 | 52 | $416M | $0 | $0 | INTC, VOD, RDSB, TTE, POT | 13F-HR | 2/12/2014, 09:59 AM |